Skip to main content

Table 2 Comparison between pre- and post-valproate (group I) treatment regarding sex hormone assay and sperm parameters

From: Effect of valproate versus levetiracetam monotherapy on reproductive functions in newly diagnosed epileptic males

Variable

Valproate (group I)

P value

Pre-treatment

Post-treatment

Sex hormones assay

• Luteinizing hormone (LH)

4.86 ± 1.8

3.4 ± 1.37

0.01*

• Follicle-stimulating hormones (FSH)

6.0 ± 2.6

4.6 ± 2.8

0.01*

• Prolactin (PRL)

8.5 ± 4.0

14.7 ± 8.4

< 0.001**

• Testosterone (T)

5.8 ± 2.0

5.4 ± 1.8

0.1

• Estradiol (E2)

25.4 ± 11.3

24.6 ± 10.9

0.9

Sperm parameters:

• Concentration

29.9 ± 12.8

25 ± 12.1

0.01*

• Total count

45.6 ± 9.0

37.6 ± 9.1

0.01*

• Total motility

58.2 ± 10.1

45.8 ± 14.0

0.001**

• Normal morphology

3.4 ± 1.4

2.88 ± 1.05

0.029*

  1. Data are represented in mean ± SD
  2. *Significant
  3. **Highly significant